SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $405,697,852 |
| Positions | 19 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| ARBUTUS BIOPHARMA CORP | ABUS | COM | $75,812,453 | 15,794,261 |
| ROIVANT SCIENCES LTD | ROIV | SHS | $36,062,410 | 1,019,000 |
| JOYY INC | JOYY | ADS REPSTG COM A | $34,641,055 | 524,944 |
| BALLYS CORPORATION | BALY | COMMON STOCK | $33,014,544 | 2,408,063 |
| GENWORTH FINL INC | GNW | COM SHS | $29,643,950 | 3,130,301 |
| NEXTNAV INC | NN | COMMON STOCK | $28,458,748 | 1,596,116 |
| OMNIAB INC | OABI | COM | $25,211,699 | 10,248,658 |
| ZIFF DAVIS INC | ZD | COM | $21,911,032 | 418,389 |
| USA TODAY CO INC | TDAY | COM | $17,141,322 | 2,004,833 |
| CADIZ INC | CDZI | COM NEW | $16,664,916 | 3,986,822 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.